AstraZeneca Releases Blueprints for Virus Vaccine Trial Amid Safety Scrutiny

Here’s what you need to know: ImageA facility in Anagni, Italy, that will assist in the production of the AstraZeneca coronavirus vaccine when it becomes available.Credit…Vincenzo Pinto/Agence France-Presse — Getty Images After coming under fire for vaccine safety, AstraZeneca releases trial blueprints. AstraZeneca revealed details of its large coronavirus vaccine trial on Saturday, the third…

Details

Study links higher level of exercise to 25% to 32% lower risk of all-cause mortality in people with type 2 diabetes

New research presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that having a greater exercise capacity is associated with a significantly decreased all-cause mortality risk of between 25-33% in people with type 2 diabetes (T2D). The study was conducted by Dr Yun-Ju…

Details

No benefit for post-operative radiotherapy in non-small-cell lung cancer

Lugano, Switzerland, 20 September 2020 – Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer. (1) PORT in completely…

Details